Jeremy Chadwick

Jeremy Chadwick, PhD, serves as the Chief Operating Officer at Kymera Therapeutics since May 2023. Previously, Jeremy held the position of Chairman of the Board of Directors at Accumulus Synergy from September 2020 to May 2023, overseeing the development of a global information exchange platform aimed at enhancing the drug approval process. During Jeremy's tenure at Takeda from January 2019 to May 2023, responsibilities included leadership roles in Global Development Operations and Global Regulatory Affairs, managing over 1,000 FTEs. Jeremy's extensive experience spans leadership roles at several pharmaceutical companies, including Palleon Pharmaceuticals and Shire, and academic credentials include a PhD in Statistics and an MS in Medical Statistics from the University of London, along with a BS in Mathematics and Statistics from De Montfort University.